Stay updated on Danirixin Safety & Efficacy in Adult Influenza Clinical Trial

Sign up to get notified when there's something new on the Danirixin Safety & Efficacy in Adult Influenza Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Danirixin Safety & Efficacy in Adult Influenza Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a recent update in the study details related to the safety, tolerability, and clinical effect of Danirixin in adults with influenza infection.
    Difference
    0.1%
    Check dated 2024-06-06T14:47:44.000Z thumbnail image
  4. Check
    6 days ago
    No Change Detected
  5. Check
    7 days ago
    No Change Detected
  6. Check
    17 days ago
    Change Detected
    Summary
    The webpage has been updated to include detailed eligibility criteria for study participants, specifying age range, symptom onset, and other health conditions required for enrollment. Previously, no information was provided under the Participation Criteria Collaborators section.
    Difference
    49%
    Check dated 2024-05-22T21:34:02.000Z thumbnail image
  7. Check
    39 days ago
    Change Detected
    Difference
    0.6%
    Check dated 2024-04-30T22:50:45.000Z thumbnail image

Stay in the know with updates to Danirixin Safety & Efficacy in Adult Influenza Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Danirixin Safety & Efficacy in Adult Influenza Clinical Trial page.